‍Is Mounjaro Better Than Wegovy for Weight Loss? 2025 Clinical Comparison

The Short Answer: Yes, Mounjaro is Clinically Superior

Mounjaro (tirzepatide) is better than Wegovy (semaglutide) for weight loss, achieving 20.2% average body weight reduction versus 13.7% in the first head-to-head trial. This represents a 47% greater relative weight loss with Mounjaro over 72 weeks.​

Head-to-Head Trial Results: SURMOUNT-5

The groundbreaking SURMOUNT-5 trial (May 2025) directly compared both medications in 750 adults with obesity (average weight 113 kg):​

Primary outcome:

• Mounjaro: 20.2% average weight loss
  
  
• Wegovy: 13.7% average weight loss
  
  
• Difference: 6.5 percentage points (47% greater with Mounjaro)​
  
  

Key secondary endpoints:

• ≥25% weight loss: 31.6% achieved with Mounjaro vs. 16.1% with Wegovy​
  
  
• ≥30% weight loss: 19.7% vs. 6.9% (2.8x higher likelihood with Mounjaro)​
  
  
• Waist circumference: 18 cm reduction vs. 13 cm​
  
  

Metabolic improvements: Mounjaro showed superior improvements in blood pressure, blood sugar, and cholesterol levels.​

Individual Trial Comparisons

Mounjaro (Tirzepatide) Results

• SURMOUNT-1: 21% average weight loss at 72 weeks (15 mg dose)​
  
  
• SURMOUNT-3: 26.6% total weight loss when combined with intensive lifestyle intervention​
  
  
• SURMOUNT-4: 25.3% weight loss maintained over 88 weeks​
  
  

Wegovy (Semaglutide) Results

• STEP-1: 14.9% average weight loss at 68 weeks (2.4 mg dose)​
  
  
• STEP-3: 16% with intensive lifestyle intervention​
  
  
• SELECT trial: Demonstrated cardiovascular risk reduction (advantage for heart health)​
  
  

Dose-Response Relationship

Mounjaro shows superior dose-dependent efficacy:

• 10 mg dose: 3.89% greater weight loss than semaglutide
  
  
• 15 mg dose: 6.50% greater weight loss than semaglutide​
  
  

Wegovy has lower ceiling: Maximum approved dose (2.4 mg) achieves less than Mounjaro's 10 mg dose.​

Who Should Choose Which?

Choose Mounjaro if:

• You need maximum weight loss (BMI ≥40 or significant comorbidities)​
  
  
• You've plateaued on semaglutide
  
  
• Cost is not the primary concern (Mounjaro is 40% more expensive in UK)​
  
  

Choose Wegovy if:

• You have cardiovascular disease (proven heart benefits)​
  
  
• You prefer established medication with longer safety data
  
  
• Cost-effectiveness is priority (lower price per kg lost)​
  
  

Side Effects: Comparable

Both cause similar gastrointestinal side effects (nausea, vomiting, diarrhea). Mounjaro's dual mechanism doesn't increase adverse events significantly.​

Bottom Line

Mounjaro is clinically superior for weight loss, delivering 20.2% vs. 13.7% average reduction in head-to-head trials. However, Wegovy remains an excellent option, particularly for cardiovascular risk reduction. Individual response varies—some patients respond better to semaglutide. Consult your doctor to determine which medication suits your health profile and goals.​

1. https://www.bbc.com/news/articles/cy75dk8kjr1o
2. https://www.eurekalert.org/news-releases/1083453
3. https://www.pharmacist.com/Blogs/CEO-Blog/Article/tirzepatide-outperforms-semaglutide-for-weight-loss
4. https://www.rheumatologyadvisor.com/news/tirzepatide-bests-semaglutide-in-head-to-head-weight-loss-trial/
5. https://www.diabetes.co.uk/news/2025/may/mounjaro-more-effective-than-wegovy-in-first-comparison-trial.html
6. https://www.ukmeds.co.uk/blog/mounjaro-or-wegovy-may-2025-weight-loss-clinical-trial-results
7. https://healthsuppliesplus.com/wegovy-vs-mounjaro-clinical-guide/
8. https://www.nice.org.uk/news/articles/nice-describes-how-weight-loss-drug-tirzepatide-will-be-rolled-out
9. https://www.nature.com/articles/s41591-023-02597-w
10. https://jamanetwork.com/journals/jama/fullarticle/2812936
11. https://joineverwell.ie/blogs/news/wegovy-vs-mounjaro-a-comprehensive-comparison-for-weight-loss
12. https://www.boltpharmacy.co.uk/guide/mounjaro-vs-wegovy-cost
13. https://pmc.ncbi.nlm.nih.gov/articles/PMC12151102/
14. https://www1.racgp.org.au/newsgp/clinical/study-compares-mounjaro-to-wegovy-for-weight-loss
15. https://www.sciencedirect.com/science/article/abs/pii/S1871402125000293
16. https://readyhealth.co.uk/blog/mounjaro-vs-wegovy-new-clinical-trial-finds-mounjaro-superior-for-weight-loss
17. https://academic.oup.com/ehjopen/article/5/5/oeaf117/8246115
18. https://www.bbc.co.uk/news/articles/c981044pgvyo
19. https://www.bhf.org.uk/informationsupport/heart-matters-magazine/medical/weight-loss-injections-explained
20. https://diabetesjournals.org/care/article/48/11/e136/163253/Weight-Reduction-With-Tirzepatide-Varied
21. https://southyorkshire.icb.nhs.uk/your-health/nices-announcement-tirzepatide-frequently-asked-questions-patients

‍